News / Business
Perrigo Company (NASDAQ:PRGO) to Hold Q1 2009 Earnings conference Call November 6
Perrigo Company (NASDAQ:PRGO) will hold a conference call on Thursday, November 6 at 8:00 am ET to discuss the first quarter earnings for 2009. The call will be hosted by Perrigo Chairman and Chief Executive Officer Joseph C. Papa. An webcast of the call will be available at perrigo.com or via phone by dialying 888-694-4676. International callers should dial 404-665-9919. The reference ID# for the call is 70124252.
Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. The three segments of the Company are Consumer Healthcare, Rx Pharmaceuticals and API.
The Company has other category that includes two operating segments, Israel Consumer Products and Israel Pharmaceutical and Diagnostic Products. In January 2008, the Company acquired Galpharm Healthcare Ltd. In the United States, its operations are conducted through L. Perrigo Company, Perrigo Company of South Carolina Inc. and Perrigo New York, Inc. Outside the United States, its operations are conducted through Perrigo Israel Pharmaceuticals Ltd., Chemagis Ltd., Quimica y Farmacia S.A. de C.V., Wrafton Laboratories Limited, Perrigo U.K. Limited and Galpharm Healthcare Ltd. In October 2008, the Company acquired
Read more Business News on The Global Market Directory.
About The Global Market Directory (TheGMD)
TheGMD is a financial networking community for Public Companies, Brokerage Firms, Stock Brokers and Individuals. Members can network and link with each other, participate in discussions on financial stock message boards, display pictures and upload videos.
The GMD is a member of the TransWorldNews, Inc. family of sites. Members can distribute press releases through The GMD and receive distribution over all TransWorldNews news outlets.
Create your profile on The Global Market Directory
